{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:57:42Z","timestamp":1774529862462,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T00:00:00Z","timestamp":1599955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T00:00:00Z","timestamp":1599955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000659","name":"Research Trainees Coordinating Centre","doi-asserted-by":"publisher","award":["DRF-2018-11-ST2-016"],"award-info":[{"award-number":["DRF-2018-11-ST2-016"]}],"id":[{"id":"10.13039\/501100000659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206602"],"award-info":[{"award-number":["206602"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Homelessness is a global issue and HIV, hepatitis C and tuberculosis are known to be prevalent in this group. Homeless populations face significant barriers to care. We aim to summarise evidence of treatment initiation and completion for homeless populations with these infections, and their associated factors, through a systematic review and meta-analysis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We will search MEDLINE, Embase and CINAHL for all study types and conference abstracts looking at either (1) treatment initiation in a cohort experiencing homelessness with at least one of HIV, hepatitis C, active tuberculosis and\/or latent tuberculosis infection (LTBI); (2) treatment completion for those who initiated treatment. We will perform a meta-analysis of the proportion of those with each infection who initiate and complete treatment, as well as analysis of individual and health system factors that may affect adherence levels. We will evaluate the quality of research papers using the Newcastle-Ottawa scale.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>Given the political emphasis on global elimination of these diseases, and the current lack of understanding of effective and equitable treatment adherence strategies in homeless populations, this review will provide insight to policy-makers and service providers aiming to improve homeless healthcare.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Systematic review registration<\/jats:title>\n<jats:p>PROSPERO CRD42019153150<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13643-020-01470-y","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T15:02:27Z","timestamp":1600009347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Protocol for a systematic review of treatment adherence for HIV, hepatitis C and tuberculosis among homeless populations"],"prefix":"10.1186","volume":"9","author":[{"given":"Luke","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3698-7196","authenticated-orcid":false,"given":"Dan","family":"Lewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair","family":"Story","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,13]]},"reference":[{"key":"1470_CR1","volume-title":"Growing privatization of property among reasons driving homelessness, UN rights expert says","author":"UN News","year":"2005","unstructured":"UN News. Growing privatization of property among reasons driving homelessness, UN rights expert says. 2005. Available from: https:\/\/news.un.org\/en\/story\/2005\/05\/137592-growing-privatization-property-among-reasons-driving-homelessness-un-rights [Accessed 28 Sept 2019]."},{"key":"1470_CR2","volume-title":"As Cities Grow, So Do the Numbers of Homeless","author":"Yale University","year":"2017","unstructured":"Yale University. As Cities Grow, So Do the Numbers of Homeless. 2017. Available from: https:\/\/yaleglobal.yale.edu\/content\/cities-grow-so-do-numbers-homeless [Accessed 28 Sept 2019]."},{"key":"1470_CR3","unstructured":"Abb\u00e9 Pierre Foundation and FEANTSA. Third Overview of Housing Exclusion in Europe. 2018. Available from: https:\/\/www.feantsa.org\/download\/full-report-en1029873431323901915.pdf [Accessed Sept 2019]."},{"key":"1470_CR4","unstructured":"National Alliance to End Homelessness. State of Homelessness. 2018. Available from: https:\/\/endhomelessness.org\/homelessness-in-america\/homelessness-statistics\/state-of-homelessness-report\/ [Accessed 28 Sept 2019]."},{"issue":"2","key":"1470_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jama.285.2.200","volume":"285","author":"MB Kushel","year":"2001","unstructured":"Kushel MB, Vittinghoff E, Haas JS. Factors associated with the health care utilization of homeless persons. JAMA. 2001;285(2):200\u20136. https:\/\/doi.org\/10.1001\/jama.285.2.200.","journal-title":"JAMA"},{"issue":"11","key":"1470_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S1473-3099(12)70177-9","volume":"12","author":"U Beijer","year":"2012","unstructured":"Beijer U, Wolf A, Fazel S. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infectious Diseases. 2012;12(11):859\u201370. https:\/\/doi.org\/10.1016\/S1473-3099(12)70177-9.","journal-title":"Lancet Infectious Diseases."},{"key":"1470_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.drugpo.2019.03.017","volume":"72","author":"ME Beiser","year":"2019","unstructured":"Beiser ME, Smith K, Ingemi M, Mulligan E, Baggett TP. Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston. Int J of Drug Policy. 2019;72:129\u201337. https:\/\/doi.org\/10.1016\/j.drugpo.2019.03.017.","journal-title":"Int J of Drug Policy."},{"key":"1470_CR8","doi-asserted-by":"publisher","unstructured":"Macbeth K, Davidson K, Anderson J. Treating hepatitis C in a dedicated GP practice for homeless patients: a multidisciplinary approach. Gastrointestinal Nursing. 2018;16(10). doi: https:\/\/doi.org\/10.12968\/gasn.2018.16.Sup10.S29.","DOI":"10.12968\/gasn.2018.16.Sup10.S29"},{"key":"1470_CR9","doi-asserted-by":"publisher","unstructured":"Laurenti P, Bruno S, Quaranta G, et al. Tuberculosis in sheltered homeless population of rome: an integrated model of recruitment for risk management. Scientific World J. 2012;396302. https:\/\/doi.org\/10.1100\/2012\/396302.","DOI":"10.1100\/2012\/396302"},{"issue":"1","key":"1470_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/apc.2011.0169","volume":"26","author":"MJ Milloy","year":"2012","unstructured":"Milloy MJ, Kerr T, Bangsberg DR, et al. Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a canadian setting. AIDS Patient Care STDS. 2012;26(1):60\u20137. https:\/\/doi.org\/10.1089\/apc.2011.0169.","journal-title":"AIDS Patient Care STDS."},{"issue":"6","key":"1470_CR11","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamainternmed.2017.0358","volume":"177","author":"JA Barocas","year":"2017","unstructured":"Barocas JA, Beiser M. Casey Le\u00f3n et al. Experience and outcomes of hepatitis C treatment in a cohort of homeless and marginally housed adults. JAMA Intern Med. 2017;177(6):880\u20132. https:\/\/doi.org\/10.1001\/jamainternmed.2017.0358.","journal-title":"JAMA Intern Med."},{"issue":"11","key":"1470_CR12","first-page":"1001","volume":"3","author":"A Southern","year":"1999","unstructured":"Southern A, Premaratne N, English M, et al. Tuberculosis among homeless people in London: an effective model of screening and treatment. Int J Tuberc Lung Dis. 1999;3(11):1001\u20131008(8).","journal-title":"Int J Tuberc Lung Dis."},{"key":"1470_CR13","doi-asserted-by":"publisher","unstructured":"Harris M, Rhodes T. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduction J. 2013;10(7). https:\/\/doi.org\/10.1186\/1477-7517-10-7.","DOI":"10.1186\/1477-7517-10-7"},{"key":"1470_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12879-019-3748-2","volume":"19","author":"JS Lambert","year":"2019","unstructured":"Lambert JS, Murtagh R, Menezes D, et al. \u2018HepCheck Dublin\u2019: an intensified hepatitis C screening programme in a homeless population demonstrates the need for alternative models of care. BMC Infec Dis. 2019;19:128. https:\/\/doi.org\/10.1186\/s12879-019-3748-2.","journal-title":"BMC Infec Dis."},{"issue":"2","key":"1470_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1515\/jtim-2017-0017","volume":"5","author":"D Crowley","year":"2017","unstructured":"Crowley D, Cullen W, Laird E, et al. Exploring patient characteristics and barriers to hepatitis c treatment in patients on opioid substitution treatment attending a community based fibro-scanning clinic. J Transl Int Med. 2017;5(2):112\u20139. https:\/\/doi.org\/10.1515\/jtim-2017-0017.","journal-title":"J Transl Int Med"},{"key":"1470_CR16","unstructured":"UNAIDS. 90-90-90 - An ambitious treatment target to help end the AIDS epidemic. 2017. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2017\/90-90-90 [Accessed 1 Oct 2019]."},{"key":"1470_CR17","unstructured":"World Health Organisation. Draft global health sector strategies: Viral hepatitis. 2016-2021:2016 Available from: http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA69\/A69_32-en.pdf?ua=1 [Accessed 1 Oct 2019]."},{"key":"1470_CR18","unstructured":"World Health Organisation. The End TB Strategy. 2014. Available from: https:\/\/www.who.int\/tb\/strategy\/End_TB_Strategy.pdf?ua=1 [Accessed 1 Oct 2019]."},{"issue":"5","key":"1470_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/1756283X15587481","volume":"8","author":"BP Lam","year":"2015","unstructured":"Lam BP, Jeffers T, Younoszai Z, et al. The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment. Therap Adv in Gastro. 2015;8(5):298\u2013312. https:\/\/doi.org\/10.1177\/1756283X15587481.","journal-title":"Therap Adv in Gastro."},{"issue":"7","key":"1470_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med."},{"key":"1470_CR21","volume-title":"World Bank Country and Lending Groups","author":"World Bank","year":"2019","unstructured":"World Bank. World Bank Country and Lending Groups. 2019. Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups [Accessed 28 Sept 2019]."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-020-01470-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-020-01470-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-020-01470-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T23:05:58Z","timestamp":1631487958000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-020-01470-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,13]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1186\/s13643-020-01470-y","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,13]]},"assertion":[{"value":"11 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}